Bolanle Olapeju1, Ahmed Saifuddin1, Guoying Wang1, Yuelong Ji1, Xiumei Hong1, Ramkripa Raghavan1, Amber Summers2, Amaris Keiser3, Hongkai Ji4, Barry Zuckerman5, Christina Yarrington6, Lingxin Hao7, Pamela J Surkan8, Tina L Cheng3, Xiaobin Wang1. 1. 1Department of Population, Family and Reproductive Health, Center on Early Life Origins of Disease,Johns Hopkins Bloomberg School of Public Health,Baltimore, MD,USA. 2. 2Center for Communication Programs,Johns Hopkins Bloomberg School of Public Health,Baltimore, MD,USA. 3. 3Department of Pediatrics,Johns Hopkins University School of Medicine,615 N. Wolfe Street, E4132, Baltimore, MD 21205-2179,USA. 4. 4Department of Biostatistics,Johns Hopkins Bloomberg School of Public Health,Baltimore, MD,USA. 5. 5Department of Pediatrics,Boston University School of Medicine and Boston Medical Center,Boston, MA,USA. 6. 6Department of Obstetrics and Gynecology,Boston University School of Medicine,Boston, MA,USA. 7. 7Department of Sociology,Johns Hopkins University,Baltimore, MD,USA. 8. 8Department of International Health,Johns Hopkins Bloomberg School of Public Health,Baltimore, MD,USA.
Abstract
OBJECTIVE: While maternal folate deficiency has been linked to poor pregnancy outcomes such as neural tube defects, anaemia and low birth weight, the relationship between folate and preterm birth (PTB) in the context of the US post-folic acid fortification era is inconclusive. We sought to explore the relationship between maternal folate status and PTB and its subtypes, i.e. spontaneous and medically indicated PTB. DESIGN: Observational study. SETTING: Boston Birth Cohort, a predominantly urban, low-income, race/ethnic minority population at a high risk for PTB.ParticipantsMother-infant dyads (n 7675) enrolled in the Boston Birth Cohort. A sub-sample (n 2313) of these dyads had maternal plasma folate samples collected 24-72 h after delivery. RESULTS: Unadjusted and adjusted logistic regressions revealed an inverse relationship between the frequency of multivitamin supplement intake and PTB. Compared with less frequent use, multivitamin supplement intake 3-5 times/week (adjusted OR (aOR) = 0·78; 95 % CI 0·64, 0·96) or >5 times/week (aOR = 0·77; 95 % CI 0·64, 0·93) throughout pregnancy was associated with reduced risk of PTB. Consistently, higher plasma folate levels (highest v. lowest quartile) were associated with lower risk of PTB (aOR = 0·74; 95 % CI 0·56, 0·97). The above associations were similar among spontaneous and medically indicated PTB. CONCLUSIONS: If confirmed by future studies, our findings raise the possibility that optimizing maternal folate levels across pregnancy may help to reduce the risk of PTB among the most vulnerable US population in the post-folic acid fortification era.
OBJECTIVE: While maternal folate deficiency has been linked to poor pregnancy outcomes such as neural tube defects, anaemia and low birth weight, the relationship between folate and preterm birth (PTB) in the context of the US post-folic acid fortification era is inconclusive. We sought to explore the relationship between maternal folate status and PTB and its subtypes, i.e. spontaneous and medically indicated PTB. DESIGN: Observational study. SETTING:Boston Birth Cohort, a predominantly urban, low-income, race/ethnic minority population at a high risk for PTB.ParticipantsMother-infant dyads (n 7675) enrolled in the Boston Birth Cohort. A sub-sample (n 2313) of these dyads had maternal plasma folate samples collected 24-72 h after delivery. RESULTS: Unadjusted and adjusted logistic regressions revealed an inverse relationship between the frequency of multivitamin supplement intake and PTB. Compared with less frequent use, multivitamin supplement intake 3-5 times/week (adjusted OR (aOR) = 0·78; 95 % CI 0·64, 0·96) or >5 times/week (aOR = 0·77; 95 % CI 0·64, 0·93) throughout pregnancy was associated with reduced risk of PTB. Consistently, higher plasma folate levels (highest v. lowest quartile) were associated with lower risk of PTB (aOR = 0·74; 95 % CI 0·56, 0·97). The above associations were similar among spontaneous and medically indicated PTB. CONCLUSIONS: If confirmed by future studies, our findings raise the possibility that optimizing maternal folate levels across pregnancy may help to reduce the risk of PTB among the most vulnerable US population in the post-folic acid fortification era.
Authors: William G Johnson; Theresa O Scholl; John R Spychala; Steven Buyske; Edward S Stenroos; Xinhua Chen Journal: Am J Clin Nutr Date: 2005-03 Impact factor: 7.045
Authors: Chantal Courtemanche; Ilan Elson-Schwab; Susan T Mashiyama; Nicole Kerry; Bruce N Ames Journal: J Immunol Date: 2004-09-01 Impact factor: 5.422
Authors: Breige McNulty; Helene McNulty; Barry Marshall; Mary Ward; Anne M Molloy; John M Scott; James Dornan; Kristina Pentieva Journal: Am J Clin Nutr Date: 2013-05-29 Impact factor: 7.045
Authors: Quan-He Yang; Heather K Carter; Joseph Mulinare; R J Berry; J M Friedman; J David Erickson Journal: Am J Clin Nutr Date: 2007-05 Impact factor: 7.045
Authors: Ramkripa Raghavan; Jacob Selhub; Ligi Paul; Yuelong Ji; Guoying Wang; Xiumei Hong; Barry Zuckerman; M Daniele Fallin; Xiaobin Wang Journal: Am J Clin Nutr Date: 2020-11-11 Impact factor: 7.045